These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31421198)

  • 21. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.
    Matozaki T; Murata Y; Okazawa H; Ohnishi H
    Trends Cell Biol; 2009 Feb; 19(2):72-80. PubMed ID: 19144521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release.
    Lian S; Xie R; Ye Y; Xie X; Li S; Lu Y; Li B; Cheng Y; Katanaev VL; Jia L
    EBioMedicine; 2019 Apr; 42():281-295. PubMed ID: 30878596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD47 in Erythrocyte Ageing and Clearance - the Dutch Point of View.
    Burger P; de Korte D; van den Berg TK; van Bruggen R
    Transfus Med Hemother; 2012 Oct; 39(5):348-52. PubMed ID: 23801927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreases in CD31 and CD47 levels on the cell surface during etoposide-induced Jurkat cell apoptosis.
    Azuma Y; Nakagawa H; Dote K; Higai K; Matsumoto K
    Biol Pharm Bull; 2011; 34(12):1828-34. PubMed ID: 22130238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses.
    Liu B; Guo H; Xu J; Qin T; Guo Q; Gu N; Zhang D; Qian W; Dai J; Hou S; Wang H; Guo Y
    MAbs; 2018; 10(2):315-324. PubMed ID: 29182441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells.
    Bian Z; Shi L; Guo YL; Lv Z; Tang C; Niu S; Tremblay A; Venkataramani M; Culpepper C; Li L; Zhou Z; Mansour A; Zhang Y; Gewirtz A; Kidder K; Zen K; Liu Y
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5434-43. PubMed ID: 27578867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The "don't eat me" signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma.
    Schürch CM; Forster S; Brühl F; Yang SH; Felley-Bosco E; Hewer E
    Oncoimmunology; 2017; 7(1):e1373235. PubMed ID: 29296529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis.
    Koh E; Lee EJ; Nam GH; Hong Y; Cho E; Yang Y; Kim IS
    Biomaterials; 2017 Mar; 121():121-129. PubMed ID: 28086180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization.
    Inamdar VV; Fitzpatrick EG; Alferiev IS; Levy RJ; Stachelek SJ; Fishbein I
    J Vis Exp; 2020 Dec; (166):. PubMed ID: 33346187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes.
    Qie Y; Yuan H; von Roemeling CA; Chen Y; Liu X; Shih KD; Knight JA; Tun HW; Wharen RE; Jiang W; Kim BY
    Sci Rep; 2016 May; 6():26269. PubMed ID: 27197045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced biocompatibility of CD47-functionalized vascular stents.
    Slee JB; Alferiev IS; Nagaswami C; Weisel JW; Levy RJ; Fishbein I; Stachelek SJ
    Biomaterials; 2016 May; 87():82-92. PubMed ID: 26914699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering antiphagocytic biomimetic drug carriers.
    Sawdon A; Peng CA
    Ther Deliv; 2013 Jul; 4(7):825-39. PubMed ID: 23883126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD47 limits antibody dependent phagocytosis against non-malignant B cells.
    Gallagher S; Turman S; Lekstrom K; Wilson S; Herbst R; Wang Y
    Mol Immunol; 2017 May; 85():57-65. PubMed ID: 28208074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies.
    Dheilly E; Moine V; Broyer L; Salgado-Pires S; Johnson Z; Papaioannou A; Cons L; Calloud S; Majocchi S; Nelson R; Rousseau F; Ferlin W; Kosco-Vilbois M; Fischer N; Masternak K
    Mol Ther; 2017 Feb; 25(2):523-533. PubMed ID: 28153099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CD47 "don't eat me signal" is highly expressed in human ovarian cancer.
    Brightwell RM; Grzankowski KS; Lele S; Eng K; Arshad M; Chen H; Odunsi K
    Gynecol Oncol; 2016 Nov; 143(2):393-397. PubMed ID: 27569584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a "Glutamine Trap" To Inhibit Lung Cancer Cell Growth.
    Wu J; Li Z; Yang Z; Guo L; Zhang Y; Deng H; Wang C; Feng M
    Mol Pharm; 2018 Aug; 15(8):3032-3045. PubMed ID: 29939755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of CD47 in vivo influences thymic dendritic cell subset proportions but not negative selection of thymocytes.
    Guimont-Desrochers F; Beauchamp C; Chabot-Roy G; Dugas V; Hillhouse EE; Dusseault J; Langlois G; Gautier-Ethier P; Darwiche J; Sarfati M; Lesage S
    Int Immunol; 2009 Feb; 21(2):167-77. PubMed ID: 19147837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages.
    Jung SH; Hwang JH; Kim SE; Young Kyu K; Park HC; Lee HT
    Xenotransplantation; 2017 May; 24(3):. PubMed ID: 28393401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of CD47-streptavidin fusion protein from bacterial lysate using biotin-agarose affinity chromatography.
    Salehi N; Peng CA
    Biotechnol Prog; 2016 Jul; 32(4):949-58. PubMed ID: 27110670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.